Cargando…
Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839803/ https://www.ncbi.nlm.nih.gov/pubmed/33515615 http://dx.doi.org/10.1016/j.ijcard.2021.01.019 |
_version_ | 1783643460392189952 |
---|---|
author | Tamargo, Juan |
author_facet | Tamargo, Juan |
author_sort | Tamargo, Juan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7839803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78398032021-01-28 Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection? Tamargo, Juan Int J Cardiol Editorial Elsevier B.V. 2021-05-15 2021-01-27 /pmc/articles/PMC7839803/ /pubmed/33515615 http://dx.doi.org/10.1016/j.ijcard.2021.01.019 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Editorial Tamargo, Juan Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection? |
title | Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection? |
title_full | Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection? |
title_fullStr | Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection? |
title_full_unstemmed | Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection? |
title_short | Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection? |
title_sort | does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a covid-19 infection? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839803/ https://www.ncbi.nlm.nih.gov/pubmed/33515615 http://dx.doi.org/10.1016/j.ijcard.2021.01.019 |
work_keys_str_mv | AT tamargojuan doesanticoagulationreducemortalityinpatientswithatrialfibrillationwholaterdevelopedacovid19infection |